Men who have sex with men (MSM) experience a high Background: burden of (CT) and (NG) Chlamydia trachomatis Neisseria gonorrhoea infections. These remain largely undiagnosed in the context of syndromic treatment. In Kenya, prevalence of rectal CT and NG infection and NG antimicrobial sensitivity are poorly described.
Introduction

Chlamydia trachomatis (CT) and Neisseria gonorrhoea (NG)
infections are curable, high-burden sexually transmitted infections (STIs) that result in considerable morbidity and mortality 1 . Global estimates of prevalence of genitourinary CT and NG infections from 2005 to 2012 were 2.7% and 0.6%, respectively, amongst men aged 15-49 years old 2 . Men who have sex with men (MSM) are a key population with regards to transmission of STIs. Worldwide, prevalence of rectal CT and NG infections in MSM has ranged as high as 21.7%-27.2% and 13.8%-25.4%, respectively 3, 4 . As a traditionally highly stigmatized population, the true burden of STI infection in MSM in sub-Saharan Africa has only been studied since 2005 5, 6 . Prevalence of rectal CT and NG has been estimated at 8% and 8% respectively in South African MSM above the age 18 7 , and 13.5% and 23.3%, respectively, in adult Nigerian MSM 8 . In Kenya, prevalence of rectal CT and/or NG was estimated to be 11.6% in a small sample of 43 human immunodeficiency virus (HIV)-negative adult MSM in the coastal region 9 and 5.2% in HIV-positive and HIV-negative MSM over the age of 18 in the west of the country 10 . In MSM, younger age, sex with men only (as opposed to sex with both men and women), transactional sexual intercourse, unprotected anal intercourse, and being HIV positive have been found to be associated with rectal CT/NG [10] [11] [12] [13] .
Over the years, the diagnosis and treatment of CT and NG infection has changed as a result of evolving technology and the development of antimicrobial resistance (AMR). Diagnosis is based on a combination of clinical suspicion, such as symptoms and signs suggestive of urethritis or proctitis, and laboratory investigations 14, 15 . Nucleic acid amplification testing (NAAT), both highly sensitive and specific in detecting CT and NG, has superseded the use of cultures for the detection of infection [15] [16] [17] . In addition, with the advent of commercial point-of-care (POC) NAAT tests such as the GeneXpert® CT/NG assay (Cepheid), results can be obtained much more rapidly (90 minutes with the GeneXpert®) 14, 16, 17 . The provision of same-day results is of particular importance in treating the MSM population, who are less likely to attend healthcare services 6 . In the context of NG infection, however, bacterial culture is still recommended to enable detection of AMR 18 .
Globally, AMR is a major threat to public health and resistance to the key antibiotic classes has been detected 19 . In Kenya, plasmid-mediated resistance of NG to penicillin and tetracycline has been shown to be more prevalent than in other countries and is likely related to extensive use of doxycycline 20 . The World Health Organization (WHO) currently recommends treating CT with either azithromycin or doxycycline 21 . Where sensitivity is unknown, the WHO recommends treating NG with ceftriaxone or cefixime combined with azithromycin. In cases where sensitivity is known, a single agent can be used 22 .
The WHO has recommended syndromic treatment of STIs as an answer to the low health-seeking behaviour and continuity of care typically seen in developing countries 23, 24 . In Kenya, first-line recommended treatment for proctitis is cefixime or ceftriaxone and azithromycin 25 . Given higher prevalence amongst MSM, the WHO recommends presumptive treatment of MSM reporting unprotected receptive anal intercourse (RAI) in the previous six months and either a partner with an STI or multiple partners 24 . Sensitivity of this approach has been estimated at 74.1% with a specificity of 45.8% in MSM in coastal Kenya 26 . This study was performed to estimate the prevalence of asymptomatic CT and NG infections in MSM reporting RAI and to assess the susceptibility of NG to commonly used antimicrobials.
Methods
Study design
The study was conducted between April 2016 and January 2017 at the Kenya Medical Research Institute (KEMRI) Mtwapa Clinic, located in a town popular for its beach tourism and nightlife. A total of 104 MSM were recruited from an ongoing cohort study of high-risk MSM; methods of recruitment into that study have been previously described 27 . Men reporting RAI in the previous 6 months and aged between 18-49 years old were included for analysis. MSM were tested for CT/NG at baseline and at a follow-up visit 6 months later. Participants who tested positive were treated accordingly; CT infection was treated with azithromycin (2 g stat dose) and doxycycline (100 mg twice a day for 7 days), NG infection with cefixime (400 mg stat dose) and azithromycin (2 g stat dose) and dual infection treated with triple therapy (cefixime, azithromycin and doxycycline). A clinician observed the participant taking cefixime, azithromycin and the first dose of doxycycline.
Collection of participant characteristics
At baseline, counsellors conducted personal interviews with the participants. Men were considered to have sex with men exclusively (MSME) as opposed to both men and women (MSMW) based on answers they had given in previous clinic visits; if they had never reported having sex with women, they were considered MSME. Participants were asked if they had received money for or paid for sex in the 3 months prior to CT/NG sample collection. Condom use and number of sexual partners was also assessed. Clinicians recorded participant complaints at the visit, and a participant was considered symptomatic of proctitis if he complained of rectal discharge, pain or an ulcer in the perianal region.
Sample collection and antimicrobial susceptibility testing for NG At baseline and follow-up, a trained clinician collected rectal swabs according to a standardized methodology: the first swab was used to detect CT and NG infection by NAAT with the GeneXpert® CT/NG Assay (Cepheid AB, Sweden), and the second was inoculated on Thayer Martin Modified agar. Inoculated plates were transported to a reference laboratory 40 km away at the end of each day for culture and antimicrobial susceptibility testing of NG 28 . A case of NG or CT infection was defined as a positive result on the GeneXpert® CT/NG assay.
The disc diffusion test was used to assess antimicrobial susceptibility of NG to ceftriaxone, penicillin and tetracycline 29 .
The Etest was performed to obtain minimum inhibitory concentrations (MIC) for cefixime and ciprofloxacin; cut-off values, as follows, were obtained from the Clinical and Laboratory Standards Institute (CLSI) 28 . For cefixime, a MIC ≤0.5 µg/ml indicated susceptibility. For ciprofloxacin, a MIC of ≤0.06 µg/ml indicated susceptibility, 0.12-0.5 µg/ml intermediate susceptibility, and ≥1 µg/ml resistance.
Data analysis
Data were analysed using Stata 13.0 (StataCorp LP, College Station, TX). Baseline participant characteristics were described. Prevalence of NG and CT at baseline and follow-up was estimated. Bivariable logistic regression was used to estimate association between participant characteristics and prevalence of CT / NG infection at baseline. Any variable with a p-value of p<0.2 was used in a multivariable regression analysis to determine adjusted odds ratios (aOR). Age was used a priori in the multivariable regression, given that the population at the clinic is principally under 25 years of age and that STIs are more prevalent in younger age groups 12, 30 . During analysis, a cut-off p-value of p<0.05 was used to indicate statistical significance.
Ethical approval
Ethical approval (protocol numbers 894 and 1224) was obtained from the KEMRI/Scientific and Ethics Review Unit (KEMRI/ SERU). Written informed consent was obtained from every participant.
Results
Participant backgrounds
Between April and July 2016, 104 participants were recruited and tested. Participant characteristics are described in full in Table 1 . Approximately half (55.8%) of those recruited were between the ages of 25-34, almost nine out of ten (87%) were never married, and approximately half (49%) received secondary education only. Half the participants (51%) were Christian, and one quarter were Muslim (26%). One in four (25%) were unemployed, with the rest either self-employed (58%) or in formal employment (17%). One in four (25%) of the participants reported unprotected sex in the week preceding testing; with a similar number indicating they had sex with men exclusively (26.9%). Half the participants had been paid for sex in the 3 months prior to the study. Just over one in three (34.6%) MSM were HIV positive.
Prevalence of CT/NG At baseline, 22 of the 104 MSM who took part in the study (21.2%) tested positive for CT and/or NG; 10 had NG (9.6%), 14 had CT (13.5%) and 2 (1.9%) had dual infection. Only one participant reported symptoms whilst the rest (95.5%) were asymptomatic ( Table 2 ). The symptomatic participant was one of the two participants co-infected with both CT and NG. At baseline, none of the 104 swabs taken for culture, including those from the ten GeneXpert® NG positive participants, grew NG.
The prevalence of CT and/or NG infection was associated with receiving payment for sex (aOR=6.2, 95%CI (1.7-22.9)) and being in formal employment (aOR=7.5, 95%CI (1.14-49.2)) on multivariable logistic regression (Table 1 ), in a model controlling for age, having sex with men only or both men and women (MSME or MSMW, respectively), employment status and receiving payment for sex in the previous three months. MSME was also associated with greater odds of prevalent CT/NG, though this did not reach statistical significance (aOR=2.5, 95%CI (0.8-7.4)).
Of the 104 participants included in the baseline analysis, 20 (19.2%) participants were lost to follow-up at 6 months ( Table 2) . Baseline CT/NG prevalence in these 20 participants was 31.8% (31.8%) compared to 18.3% in those who attended followup, although this difference was not statistically significant (p=0.217). In total, 21 (25%) of 84 participants at follow-up tested positive for CT and/or NG infection; 12 (14.3%) participants had CT, 12 (14.3%) had NG, and 3 (3.6%) had dual infection. In total, 5 of the 21 (23.8%) cases of CT or NG that tested positive for CT or NG at follow-up were also positive at baseline; 5 had CT and 1 NG (1 CT and NG co-infection). All 21 follow-up participants were asymptomatic ( Table 2) . NG was isolated from six of twelve GeneXpert® NG positive follow-up participants (50%).
Antimicrobial susceptibility of N. gonorrhoea Out of the 188 cultures performed (104 at baseline, 84 at follow-up), only 6 (3.2%) isolated NG; all six had been detected by the GeneXpert® NAAT and were isolated from follow-up samples. The NG isolates were found to be 100% resistant to tetracycline and ciprofloxacin, partially resistant to penicillin (33% resistant, 67% intermediate susceptibility), and 100% sensitive to ceftriaxone and cefixime ( Figure 1 ).
Discussion
This study assessed the prevalence of rectal CT and NG in 104 MSM, identifying one in five participants at baseline and one in four participants at follow-up who were infected with either or both infections. A similarly high prevalence of CT/NG infections were reported from other parts of sub-Saharan Africa [7] [8] [9] [10] . Prevalence at baseline was statistically associated with receiving money for sexual intercourse-a four-fold increase in oddswhich is consistent with the findings from previous studies 7, 11, 31 . Men who engage in transactional sex may have increased vulnerability to STIs, which is compounded by an increased burden of psychosocial morbidities, such as stigmatization and discrimination 31 . Being in formal employment was also associated with prevalent infection with CT/NG. This may possibly indicate that formal employment leads to greater financial means and thus a greater likelihood of paying for sex, although paying for sex was not found to be statistically associated with rectal CT/NG in this study.
The WHO recommends that CT/NG infections should be detected and treated in a timely manner, by either presumptive treatment or syndromic treatment 21, 22, 24 . This is particularly important as these infections can remain undiagnosed for a long time unless routinely screened for, and thus be easily transmitted to other sexual partners. In this study, 95.5% of infections at baseline and 100% of infections at follow-up were asymptomatic. There are more asymptomatic cases of anorectal CT/NG reported in this study compared to other studies on MSM from the USA (58% asymptomatic CT, and 69% asymptomatic NG) 32 and Kenya (58.3% asymptomatic CT/NG infection) 10 . This may be a true picture of the burden of infection in coastal Kenya, but larger research studies are needed to confirm these findings. Nevertheless, this finding does support the need for more etiologic diagnosis when and where possible programmes to detect asymptomatic infections in developing countries, particularly in high-risk populations such as MSM 33, 34 .
No NG was isolated from baseline rectal swabs in GeneXpert® NG-positive participants. At follow-up, six NG isolates were successfully cultured from 12 GeneXpert® NG positive participants. The only methodological difference at follow-up was prior notification of the laboratory at the reference centre 40 km away that a participant was positive on the GeneXpert® assay, one extra day of incubation was added to give more time to the scanty colonies to grow. It is well recognized that test methodology and technical expertise have an impact on the positivity rates of samples. Hence, antimicrobial susceptibility testing may be more reliably evaluated using rapid molecular POC tests in the future 35 . The low yield in this case may also be due to the practicalities of having to transport the culture plates to the reference laboratory and the order of swab collections. As the culture swab was taken last, the bacterial yield may have been insufficient to result in a positive culture.
Regardless of yield, antimicrobial susceptibility testing revealed that all cultured NG isolates were sensitive to cefixime (first line treatment for NG) and ceftriaxone, and that all isolates were resistant to tetracycline and ciprofloxacin (Figure 1 ). Though azithromycin sensitivity was not assessed and baseline cultures were negative, the susceptibility of NG to cefixime at follow-up suggests that all treated participants were cured. Previous susceptibility studies of NG have shown that AMR is rising globally, and is a very real threat to healthcare systems, particularly for those caring for high-risk populations 19, 20, 36, 37 . Genomic studies have demonstrated that resistant NG strains are transmitted between MSM partners 36 . This information calls for careful treatment of NG, and for routine antimicrobial susceptibility testing to be performed where possible. It is crucial that global guidelines on STI treatment in MSM and other key populations be updated to take into account AMR and POC testing 21, 22 .
Approximately one-third of participants in this study (34.6%) were HIV positive, though this was not statistically associated with CT/NG prevalence. HIV infection has been found to be higher in participants with an underlying STI, presumably facilitated by inflammation of mucosal epithelium 38,39 . It is therefore critical to rapidly detect and treat STIs in order to minimize future HIV-related epidemics in the MSM populations 39 . Several studies have looked at the association between pre-exposure prophylaxis (PrEP) and the incidence of STIs: these studies demonstrated increased rates of CT/NG infections with PrEP use, potentially related to increased screening for STIs, increased condomless sexual intercourse and decreased serosorting between sexual contacts 40, 41 . Several months after this study concluded, HIV-negative MSM in the same larger cohort started receiving PrEP; it will be interesting to assess the impact this has on CT/NG infection rates in this population.
This study has several limitations. The sample size was small, rendering statistical analysis and interpretation of results for subgroups difficult. Furthermore, the small yield of NG cultures highlights the difficulty of generalizing resistance data, azithromycin resistance had not been assessed and this calls for larger studies of antimicrobial resistance in Kenya.
Conclusion
The prevalence of rectal CT/NG infections in MSM who report RAI in coastal Kenya is estimated to be between 21.2% and 25%, and is associated with transactional sex and formal employment. All but one of the participants who tested positive for CT/NG infection were asymptomatic, supporting the use of a presumptive treatment approach. All positive NG infections were treated with cefixime and azithromycin; all NG isolates were sensitive to cefixime/ceftriaxone. The study findings suggest a need for continued surveillance of NG antimicrobial susceptibility and for sharing of data between research groups studying NG in Kenya. 
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Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland Thank you for giving me the opportunity to review this manuscript, which addresses the important issue of extra-genital sexually transmitted infections (STI) in men who have sex with men (MSM) in Kenya. I have no concerns about the relevance and validity of the data. The study is small but, on the other hand, has detailed behavioural information, antimicrobial susceptibility data and a follow-up visit. The findings lack statistical precision, so the authors are restricted in the certainty of the conclusions that they can draw. In this situation, data from such studies are very important for future syntheses of evidence in systematic reviews.
In Wellcome Open Research, I think the authors have more flexibility about what to report, meaning that there is an opportunity for useful contextual information about the study and for full reporting that will make the findings reproducible and able to be used in a future systematic review. I have some suggestions that I hope the authors will find useful in revising their manuscript.
Major comments
Study design: this is a report of a cohort study, nested within a larger cohort study. Please make sure that all the items proposed in the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) checklist for cohort studies ( ) are reported. In particular, I https://www.strobe-statement.org/index.php?id=available-checklists would like to see: a) the proportion enrolled and whether or not they differed from the men in the larger cohort study. The authors only report (p4, Results, Participant backgrounds, line 1), "104 participants were recruited and tested"; b) the follow-up time reported as a total number of months and average for each participant; 95% confidence intervals (CI) for the main percentages.
Study design: Can the authors say whether this study was pre-planned? If so, was there a target sample size with a power calculation? Was enrolment less than expected?
Data analysis: can the authors please calculate and report the incidence rate of Chlamydia (CT) and (NG) detection in anorectal samples? The availability trachomatis Neisseria gonorrhoeae of data from a follow-up visit is a strength of the study. Prevalence at follow-up (p4, Methods, Data analysis, line 3, and Table 2 ) isn't very useful. It would be great to change the columns in Table 2 to 6.
7.
8.
9.
10.
11.
12.
13.
14.
without proctoscopy, which sample mainly from the anal canal might be more accurately termed as "anorectal".
Data analysis (p4, Methods, line 4): "bivariable" is ambiguous. When the model examines an association between an outcome and one other variable, it is usual to call this a univariable analysis.
Data analysis and Table 1 : the p-values are given for each stratum (e.g. age, religion). In the multivariable statistical model, it is the contribution of the variable as a whole that is important. These 'global' p values should be derived from a likelihood ratio test that compares the model fit with the variable to the model that includes all variables other than the one of interest. For a binary variable the results are the same. Discussion: This could be better structured. It is important that you collected data about infections, behaviours and antimicrobial susceptibility. Both presumptive treatment and frequent screening and treatment impose selection pressure for the emergence of antimicrobial resistance. The discussion is an opportunity to bring together these lines of thought in thinking about how to address rectal STIs in MSM.
Discussion, Limitations (p7): It's worth mentioning the limitation of having combined the data for CT and NG owing to the small sample size. Conclusion (p7): "…between 21.2% and 25%." These point estimates suggest spurious precision and lower 95% CI is much lower. I expect each estimate lies within the confidence interval of the other, given the sample size. Please rephrase in context of confidence intervals.
Conclusions: in Abstract (p1, and main text (p7) don't match. In the Abstract, there is no support from the results that "The high prevalence of asymptomatic rectal CT and NG in MSM reporting RAI demonstrates the need for frequent screening". The more cautious statements in the main text are more appropriate. Figure 3 and, for each antimicrobial tested, the MIC for each isolate could be shown. In the text, the absolute numbers are more useful than the percentages. Many thanks for these comments. We have included a Table 3 instead of Figure 1 , which presents the data you have suggested. In addition, we have written down whole numbers instead of percentages when describing the AMR data in the manuscript. This is a useful report of rectal gonorrhea and chlamydia in MSM in coastal Kenya. The Introduction suffers from missing some crucial findings from a similar study of prevalence of rectal NG/CT in MSM in Tanga and Dar es Salaam, a few hundred miles south of where this study was carried out (Ross MW et al ., BMJ Open 2014) . Some of those interesting findings were replicated, including the lack of association between HIV and STI in MSM, plus similar high rates of rectal STIs. There may be lessons here about access to clinics that will perform rectal examinations/swabs, especially if the MSM are not "out" to health care workers (rectal STIs are a marker for MSM activity and likely to engender discriminatory behavior in many health workers). Religion was given for 77%, but what was the other quarter? Hindi? No religion?
Minor comments The causative agent of gonorrhoea is Neisseria gonorrhoeae (not gonorrhoea
